The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Synthesis and biological activity of pyrrole, pyrroline and pyrrolidine derivatives with two aryl groups on adjacent positions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radul, O. M., Bukhanyuk, S. M., Rekhter, M. D., Zhungietu, G. I., & Ivanova, I. (1982) · Cited by 10,653
The role of protein kinase C in cell surface signal transduction and tumour promotion
Nishizuka, Y. (1984) · Nature · doi:10.1038/308693a0 · Cited by 7,454
Multicomponent Reactions with Isocyanides
Dömling, A., & Ugi, I. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20000915)39:18<3168::aid-anie3168>3.0.co;2-u · Cited by 4,077
Comprehensive organic chemistry
Barton, D., & Ollis, W. D. (1978) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)85753-1 · Cited by 2,795
(2003) · Elsevier eBooks · doi:10.1016/c2009-0-22714-0 · Cited by 2,592
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., & Loriolle, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98476-0 · Cited by 2,456
Chemistry of Heterocyclic Compounds: Fused Pyrimidines, Part II: Purines
(1971) · Chemistry of Heterocyclic Compounds: A Series Of Monographs · doi:10.1002/9780470186886 · Cited by 2,450
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Notz, W., Tanaka, F., & Barbas, C. F. (2004) · Accounts of Chemical Research · doi:10.1021/ar0300468 · Cited by 1,370
Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids (1998 to 1999)
O’Hagan, D. (2000) · Natural Product Reports · doi:10.1039/a707613d · Cited by 1,249
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Procter, G. (1996) · doi:10.1093/oso/9780198557265.001.0001 · Cited by 1,136
Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 897
Oxidative C−H Activation/C−C Bond Forming Reactions: Synthetic Scope and Mechanistic Insights
Kalyani, D., Deprez, N. R., Desai, L. V., & Sanford, M. S. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051402f · Cited by 796
Stauffer, S. R., Coletta, C. J., Tedesco, R., Nishiguchi, G., Carlson, K., Sun, J., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000170m · Cited by 760
Handbook of heterocyclic chemistry
(2011) · Choice Reviews Online · doi:10.5860/choice.48-6296 · Cited by 745
OMURA, S., IWAI, Y., HIRANO, A., NAKAGAWA, A., AWAYA, J., TSUCHIYA, H., TAKAHASHI, Y., & ASUMA, R. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.275 · Cited by 674
Cyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
Catalyzed Addition of Aldehydes to Activated Double Bonds—A New Synthetic Approach
Stetter, H. (1976) · Angewandte Chemie International Edition in English · doi:10.1002/anie.197606391 · Cited by 622
Recent advances in isocyanide-based multicomponent chemistry
Dömling, A. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00328-9 · Cited by 462
Structure−Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists
Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S. R., McCallion, D., Pertwee, R., & Makriyannis, A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980363y · Cited by 447
Felpin, F., & Lebreton, J. (2003) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200300193 · Cited by 442
Wang, L., Woods, K. W., Li, Q., Barr, K. J., McCroskey, R. W., Hannick, S. M., Gherke, L., Credo, R. B., Hui, Y.-H., Marsh, K. G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010523x · Cited by 422
Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6
Pettit, G. R., Singh, S. B., Boyd, M. R., Hamel, E., Pettit, R. K., Schmidt, J. M., & Hogan, F. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00010a011 · Cited by 396
p38 MAP kinase: a convergence point in cancer therapy
Olson, J. M., & Hallahan, A. R. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.01.007 · Cited by 335
Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action
Eldar-Finkelman, H., & Krebs, E. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9660 · Cited by 319
Welsh, G. I., Miller, C. M., Loughlin, A. J., & Price, N. T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01548-2 · Cited by 298
Nishizuka, Y. (1989) · Cancer · doi:10.1002/1097-0142(19890515)63:10<1892::aid-cncr2820631005>3.0.co;2-z · Cited by 290
Cox-2-Selective Inhibitors: The New Super Aspirins
DeWitt, D. L. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23023-6 · Cited by 261
N-(Triisopropylsilyl)pyrrole. A progenitor "par excellence" of 3-substituted pyrroles
Bray, B. L., Mathies, P. H., Naef, R., Solas, D. R., Tidwell, T. T., Artis, D. R., & Muchowski, J. M. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00313a019 · Cited by 238
1 The Discovery and Development of Atorvastatin, A Potent Novel Hypolipidemic Agent
Roth, B. D. (2002) · Progress in Medicinal Chemistry · doi:10.1016/s0079-6468(08)70080-8 · Cited by 233
Gans, K. R., Galbraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E., & Ackerman, N. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12610-4 · Cited by 231
van Leusen, A. M., Siderius, H., Hoogenboom, B. E., & van Leusen, D. (1972) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)85244-8 · Cited by 227
Combretastatins: from natural products to drug discovery
Cirla, A., & Mann, J. (2003) · Natural Product Reports · doi:10.1039/b306797c · Cited by 218
Davis, P. D., Elliott, L. H., Harris, W., Hill, C. H., Hurst, S. A., Keech, E., Kumar, M. K. H., Lawton, G., Nixon, J. S., & Wilkinson, S. E. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00084a004 · Cited by 213
Liverton, N. J., Butcher, J. W., Claiborne, C. F., Claremon, D. A., Libby, B. E., Nguyen, K. T., Pitzenberger, S. M., Selnick, H. G., Smith, G. R., Tebben, A., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9805236 · Cited by 196
Quesada, A., García Grávalos, M., & Fernández Puentes, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.421 · Cited by 195
Protein kinase C in transmembrane signalling
Farago, A., & Nishizuka, Y. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81284-u · Cited by 195
Lamellarin D: a novel potent inhibitor of topoisomerase I.
Facompré, M., Tardy, C., Mahieu, C., Colson, P., Perez, C., Manzanares, I., Cuevas, C., & Bailly, C. (2003) · PubMed · Cited by 194
Synthesis and antioxidant activity of new tetraarylpyrroles
Lehuédé, J., Fauconneau, B., Barrier, L., Ourakow, M., Piriou, A., & Vierfond, J.-M. (1999) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(99)00111-7 · Cited by 189
Total Synthesis and Biological Activity of Lactacystin, Omuralide and Analogs.
COREY, E. J., & LI, W.-D. Z. (1999) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.47.1 · Cited by 189
1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2
Khanna, I. K., Weier, R. M., Yu, Y., Collins, P. W., Miyashiro, J. M., Koboldt, C. M., Veenhuizen, A. W., Currie, J. L., Seibert, K., & Isakson, P. C. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970036a · Cited by 171
Potent, orally absorbed glucagon receptor antagonists
de Laszlo, S. E., Hacker, C., Li, B., Kim, D., MacCoss, M., Mantlo, N., Pivnichny, J. V., Colwell, L., Koch, G. E., Cascieri, M. A., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00081-5 · Cited by 169
Yeh, H.-C., Wu, W.-C., Wen, Y.-S., Dai, D.-C., Wang, J.-K., & Chen, C.-T. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo049512c · Cited by 169
Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides
Davis, P. D., Hill, C. H., Lawton, G., Nixon, J. S., Wilkinson, S. E., Hurst, S. A., Keech, E., & Turner, S. E. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a024 · Cited by 159
Deidda, D., Lampis, G., Fioravanti, R., Biava, M., Porretta, G. C., Zanetti, S., & Pompei, R. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3035 · Cited by 159
Khanna, I., Weier, R. M., Yu, Y., Xu, X. D., Koszyk, F. J., Collins, P. W., Koboldt, C. M., Veenhuizen, A. W., Perkins, W. E., Casler, J. J., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9700225 · Cited by 152
New alkaloids of the lamellarin class from the marine ascidian Didemnum chartaceum (Sluiter, 1909)
Lindquist, N., Fenical, W., Duyne, G. D. V., et al. (1988) · The Journal of Organic Chemistry · doi:10.1021/jo00254a029 · Cited by 143
Warabi, K., Matsunaga, S., van Soest, R. W. M., & Fusetani, N. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo0267910 · Cited by 143
Kato, A., Adachi, I., Miyauchi, M., Ikeda, K., Komae, T., Kizu, H., Kameda, Y., Watson, A. A., Nash, R. J., Wormald, M. R., et al. (1999) · Carbohydrate Research · doi:10.1016/s0008-6215(99)00043-9 · Cited by 128
Berlinck, R. G. S., Britton, R., Piers, E., Lim, L., Roberge, M., da Rocha, R. M., & Andersen, R. J. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo981607p · Cited by 128
New Lamellarin Alkaloids from the Australian Ascidian, Didemnum chartaceum
Davis, R. A., Carroll, A. R., Pierens, G. K., & Quinn, R. J. (1999) · Journal of Natural Products · doi:10.1021/np9803530 · Cited by 122
Pyrroles and other heterocycles as inhibitors of P38 kinase
de Laszlo, S. E., Visco, D. M., Agarwal, L., Chang, L. L., Chin, J., Croft, G. F., Forsyth, A., Fletcher, D. S., Frantz, B., Hacker, C., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00495-8 · Cited by 121
Pyrroles and their Benzo Derivatives: Synthesis
Sundberg, R. J. (1996) · Elsevier eBooks · doi:10.1016/b978-008096518-5.00042-3 · Cited by 116
Mitogen‐activated protein kinases and asthma
Pelaia, G., Cuda, G., Vatrella, A., Gallelli, L., Caraglia, M., Marra, M., Abbruzzese, A., Caputi, M., Maselli, R., Costanzo, F. S., et al. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20169 · Cited by 109
Adams, J. L., Boehm, J. C., Gallagher, T. F., Kassis, S., Webb, E. F., Hall, R., Sorenson, M. E., Garigipati, R. S., Griswold, D. E., & Lee, J. C. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00570-4 · Cited by 107
The p38 MAP kinase signaling pathway in Alzheimer's disease
Johnson, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00268-1 · Cited by 106
Engler, T. A., Henry, J. R., Malhotra, S., Cunningham, B., Furness, K., Brozinick, J. T., Burkholder, T. P., Clay, M. P., Clayton, J. R., Diefenbacher, C. G., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049768a · Cited by 106
Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1 H -pyrroles in SLM and STZ models
Goel, A., Agarwal, N., Singh, F. V., Sharon, A., Tiwari, P., Dixit, M., Pratap, R., Srivastava, A. K., Maulik, P. R., & Ram, V. J. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.009 · Cited by 103
Halitulin, a new cytotoxic alkaloid from the marine sponge Haliclona tulearensis
Kashman, Y., Koren‐Goldshlager, G., Gravalos, M. D. G., et al. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)02467-8 · Cited by 96
Panda, D., Daijo, J., Jordan, M. A., & Wilson, L. (1995) · Biochemistry · doi:10.1021/bi00031a014 · Cited by 94
Recent Developments of Rebeccamycin Analogues as Topoisomerase I Inhibitors and Antitumor Agents.
Prudhomme, M. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374138 · Cited by 94
Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ
Faul, M. M., Gillig, J. R., Jirousek, M. R., Ballas, L. M., Schotten, T., Kahl, A., & Mohr, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00286-5 · Cited by 93
Trinks, U. P., Buchdunger, E., Furet, P., Kump, W. G., Mett, H., Meyer, T., Mueller, M., Regenass, U., & RIHS, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00033a019 · Cited by 91
Polycitone A and Polycitrins A and B: New Alkaloids from the Marine Ascidian Polycitor sp
Rudi, A., Goldberg, I., Stein, Z., et al. (1994) · The Journal of Organic Chemistry · doi:10.1021/jo00084a015 · Cited by 91
Francisco, M. E. Y., Seltzman, H. H., Gilliam, A. F., Mitchell, R. A., Rider, S. L., Pertwee, R. G., Stevenson, L., & Thomas, B. F. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010498v · Cited by 88
A Complex Pyrrolo‐oxazinone and Its Iodo Derivative Isolated from a Tunicate
Yoshida, W. Y., Lee, K. K., Carroll, A. R., et al. (1992) · Helvetica Chimica Acta · doi:10.1002/hlca.19920750525 · Cited by 87
Synthesis and Cytotoxicity of 3,4-Diaryl-2(5H)-furanones
Kim, Y. D., Nam, N., You, Y., & Ahn, B. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00831-9 · Cited by 84
van den Nieuwendijk, A. M. C. H., Pietra, D., Heitman, L. H., Göblyös, A., & IJzerman, A. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030863d · Cited by 84
Kuo, G., Prouty, C. P., DeAngelis, A., Shen, L., O’Neill, D. J., Shah, C. R., Connolly, P. J., Murray, W. V., Conway, B. R., Cheung, P., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030115o · Cited by 83
New Sources of Dietary Myosmine Uptake from Cereals, Fruits, Vegetables, and Milk
Tyroller, S., Zwickenpflug, W., & Richter, E. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf020281p · Cited by 81
Interactions of LY333531 and Other Bisindolyl Maleimide Inhibitors with PDK1
Komander, D., Kular, G. S., Schüttelkopf, A. W., Deák, M., Prakash, K. R. C., Bain, J., Elliott, M., Garrido-Franco, M., Kozikowski, A. P., Alessi, D. R., et al. (2004) · Structure · doi:10.1016/j.str.2004.01.005 · Cited by 79
The Development of Cannabinoid Antagonists
Barth, F., & Rinaldi, M. L. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401143808 · Cited by 77
Pluotno, A., & Carmeli, S. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.11.016 · Cited by 76
Cyclooxygenase (COX) Inhibitors: A Comparative QSAR Study
Garg, R., Kurup, A., Mekapati, S. B., & Hansch, C. H. (2003) · Chemical Reviews · doi:10.1021/cr020464a · Cited by 76
Potential of p38 inhibitors in the treatment of rheumatoid arthritis.
Foster, M., Halley, F., & Souness, J. (2000) · PubMed · Cited by 71
Peschko, C., Winklhofer, C., & Steglich, W. (2000) · Chemistry - A European Journal · Cited by 71
Synthesis of substituted bis(heteroaryl)maleimides
Dubernet, M., Caubert, V., Guillard, J., & Viaud‐Massuard, M. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.03.016 · Cited by 66
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3
Zhang, H., Ye, H., Conway, B. R., Derian, C. K., Addo, M. F., Kuo, G., Hecker, L. R., Croll, D. R., Li, J., Westover, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(04)00463-9 · Cited by 66
Saravanan, P., & Corey, E. J. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo0268916 · Cited by 65
The development of potent and selective bisarylmaleimide GSK3 inhibitors
Engler, T. A., Malhotra, S., Burkholder, T. P., Henry, J. R., Mendel, D., Porter, W. J., Furness, K., Diefenbacher, C. G., Marquart, A. L., Reel, J. K., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.063 · Cited by 65
Loya, S., Rudi, A., Kashman, Y., & Hizi, A. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440085 · Cited by 64
Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.
Pargellis, C., & Regan, J. R. (2003) · PubMed · Cited by 64
Joy, S. V., Scates, A. C., Bearelly, S., Dar, M. S., Taulien, C. A., Goebel, J. A., & Cooney, M. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e572 · Cited by 60
Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis
Révész, L., Blum, E., Padova, F. E. D., Buhl, T., Feifel, R., Gram, H., HIESTAND, P. C., Manning, U., & Rucklin, G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.106 · Cited by 60
Piers, E., Britton, R., & Andersen, R. J. (1999) · The Journal of Organic Chemistry · doi:10.1021/jo9914723 · Cited by 60
Novel 4,5-Diaryl-3-hydroxy-2(5H)-furanones as Anti-Oxidants and Anti-Inflammatory Agents
Weber, V., Coudert, P., Rubat, C., Duroux, E., Vallee‐Goyet, D., Gardette, D., Bria, M., Albuisson, E., Leal, F., Gramain, J., et al. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00053-6 · Cited by 52
Göblyös, A., de Vries, H., Brussee, J., & IJzerman, A. P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049337s · Cited by 49
Antimicrobial activities of indolocarbazole and bis-indole protein kinase C inhibitors.
Sancelme, M., Fabre, S., & Prudhomme, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.792 · Cited by 48
Atorvastatin Calcium: An Addition to HMG‐CoA Reductase Inhibitors
Chong, P. H., & Seeger, J. D. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03081.x · Cited by 47
Gill, A. L., Cleasby, A., & Jhoti, H. (2005) · ChemBioChem · doi:10.1002/cbic.200400188 · Cited by 46
Identification of a dehydrodimer of avenanthramide phytoalexin in oats
Okazaki, Y., Ishihara, A., Nishioka, T., & Iwamura, H. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.04.008 · Cited by 45
Han, Z., Pantazis, P., Lange, T. S., Wyche, J. H., & Hendrickson, E. A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400681 · Cited by 45
p38 mitogen-activated protein kinase inhibitors for the treatment of chronic cardiovascular disease.
Behr, T. M., Berova, M., Doe, C. P. A., et al. (2003) · PubMed · Cited by 45
Nakatani, S., Naoe, A., Yamamoto, Y., Yamauchi, T., Yamaguchi, N., & Ishibashi, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00592-4 · Cited by 44
Sánchez-Martı́nez, C., Shih, C., Zhu, G., Li, T., Brooks, H. B., Patel, B. K. R., Schultz, R. M., DeHahn, T. B., Spencer, C. D., Watkins, S. A., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00792-3 · Cited by 43
Antiinflammatory 4,5-Diarylpyrroles: Synthesis and QSAR
Wilkerson, W. W., Galbraith, W., Gans-Brangs, K. R., Grubb, M. F., Hewes, W. E., JAFFEE, B. D., Kenney, J., Kerr, J., & Wong, N. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00033a017 · Cited by 42
Recent advances in CB1 cannabinoid receptor antagonists.
Lange, J. H. M., & Kruse, C. G. (2004) · PubMed · Cited by 40
Shen, L., Prouty, C. P., Conway, B. R., Westover, L., Xu, J., Look, R. A., Chen, X., Beavers, M. P., Roberts, J. R., Murray, W. V., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.047 · Cited by 36
Potential of p38 MAP kinase inhibitors in the treatment of cancer
Schultz, R. M. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8012-1_2 · Cited by 33
Crane, S. N., & Corey, E. J. (2001) · Organic Letters · doi:10.1021/ol015757p · Cited by 33
p38 Mitogen Activated Protein Kinase as a Therapeutic Target for Alzheimer's Disease
Dalrymple, S. A. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:295 · Cited by 30
Bosch, J., Roca, T., Catena, J., Llorens, O., Pérez, J. J., Lagunas, C., Fernández, A. G., Miquel, I., Fernandez‐Serrat, A., & Farrerons, C. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00329-2 · Cited by 28
Yee, N. K., Nummy, L. J., Byrne, D. P., SMITH, L. L., & Roth, G. P. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo971605p · Cited by 27
Effects of the allosteric modulator SCH-202676 on adenosine and P2Y receptors
Gao, Z., Gross, A. S., & Jacobson, K. A. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.11.014 · Cited by 26
Grimshaw, J., & Hewitt, S. A. (1990) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19900002995 · Cited by 25
Miwatashi, S., Arikawa, Y., Naruo, K., Igaki, K., Watanabe, Y., Kimura, H., Kawamoto, T., & Ohkawa, S. (2005) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.53.410 · Cited by 24
Yee, N. K. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)01134-9 · Cited by 19
A Highly Enantiopure Biconcave Porphyrin with Effective D 4-Structure
Schwenninger, R., Ramondenc, Y., Wurst, K., Schlögl, J., & Kräutler, B. (2000) · Chemistry - A European Journal · doi:10.1002/(sici)1521-3765(20000403)6:7<1147::aid-chem1147>3.0.co;2-1 · Cited by 15
Sloop, K. W., & Michael, M. D. (2004) · Drugs of the Future · doi:10.1358/dof.2004.029.08.854175 · Cited by 15
Asakai, R., Aoyama, Y., & Fujimoto, T. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00151-7 · Cited by 11
Cited by
Transition Metal-Mediated Synthesis of Monocyclic Aromatic Heterocycles
Gulevich, A. V., Dudnik, A. S., Chernyak, N., & Gevorgyan, V. (2013) · Chemical Reviews · doi:10.1021/cr300333u · Cited by 1,010
Arylglyoxals in Synthesis of Heterocyclic Compounds
Eftekhari-Sis, B., Zirak, M., & Akbari, A. (2013) · Chemical Reviews · doi:10.1021/cr300176g · Cited by 453
Hu, X., Chen, J., Wei, Q., Liu, F., Deng, Q., Beauchemin, A. M., & Xiao, W. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201406491 · Cited by 301
Liu, J., Fang, Z., Zhang, Q., Liu, Q., & Bi, X. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302024 · Cited by 299
Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles
Bellina, F., Cauteruccio, S., & Rossi, R. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.02.075 · Cited by 254
Self-citation
Metadata
- Authors
- Bellina, F., & Rossi, R.
- Venue
- Tetrahedron
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 62
- Issue
- 31
- Pages
- 7213-7256
- ISSN
- 0040-4020 (ISSN-L)
- OpenAlex
- W2950979937
- Cited by
- 606
- References
- 112
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.